Steven Romano

Steven Romano

Chief Tech/Sci/R&D Officer at SILENCE THERAPEUTICS PLC

Net worth: 23 387 $ as of 2025-11-29

66 year
Health Technology
Commercial Services
Consumer Services

Profile

Steven Joseph Romano is currently Chairman at National Pharmaceutical Council since 2021, Director at Evolution Research Group LLC, Independent Director at Dianthus Therapeutics, Inc. since 2024, and Chief Research & Development, Executive VP at Silence Therapeutics Plc since 2019.
Former roles include Senior VP & Head-Global Medicines Development at Pfizer Inc. from 1999 to 2015, Chief Scientific Officer & Executive VP at Keenova Therapeutics Plc from 2015 to 2022, Chief Scientific Officer & Executive VP at Mallinckrodt Pharmaceuticals Ltd. from 2015 to 2022, and President of the International Society For CNS Clinical Trials & Methodology.
Education includes undergraduate studies at Washington University in St. Louis and a doctorate from the University of Missouri School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 12,993 ( 0.01% ) 23 387 $ 2025-11-29
2026-05-20 0 ( -.--% ) - $ 2026-05-30

Steven Romano active positions

CompaniesPositionStart
SILENCE THERAPEUTICS PLC Chief Tech/Sci/R&D Officer 2023-03-31
DIANTHUS THERAPEUTICS, INC. Director/Board Member 2024-09-15
Chairman 2021-11-03
Director/Board Member -

Former positions of Steven Romano

CompaniesPositionEnd
MALLINCKRODT PLC Chief Tech/Sci/R&D Officer 2022-12-30
Chief Tech/Sci/R&D Officer 2022-11-30
PFIZER INC. Corporate Officer/Principal 2015-04-30
International Society For Cns Clinical Trials & Methodology
President -
See the detail of Steven Romano's experience

Training of Steven Romano

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

85

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Health Technology

International Society For Cns Clinical Trials & Methodology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!